Senate Debates $8 Billion for Bird Flu Plan
Proposed Bill Includes New Funds for Purchase of Vaccines
WebMD News Archive
Oct. 26, 2005 -- Senate Democrats pushed an $8 billion bird flu preparedness
package on Wednesday, more than double a $3.9 billion preparedness measure
passed by senators less than one month ago.
Supporters said the additional spending was needed because the U.S. remains
highly vulnerable to bird flu.
But Republicans dismissed the bill, saying it was being used to politicize
public concern over the disease.
The new bill, which is likely to face a vote on Thursday, seeks $3.3 billion
to stockpile a
against H5N1, the virus that causes bird flu. The federal
government signed a $100 million deal with vaccine maker Sanofi Pasteur to
begin manufacturing a still-experimental vaccine for eventual U.S.
The bill also would devote $3.1 billion to purchase antiviral drugs like
Tamiflu. Tamiflu and Relenza can be used both to treat and prevent flu
infections. Although bird flu has developed Tamiflu resistance in some treated
individuals, this is not unexpected. And flu viruses resistant to Tamiflu don't
spread very well. Governments worldwide have scrambled to buy these antiviral
drugs because it may have the ability to slow or mitigate the effects of bird
flu in people.
The U.S. has stockpiled only 2.3 million doses of antiviral drugs and has
contracted to buy several times more. Still, the purchase is far below a World
Health Organization recommendation that countries secure enough antiviral
medication to treat 40% of the population. The stockpiles are enough to treat
less than 1% of the U.S. population.
"There's no question the United States is now woefully unprepared for an
outbreak of human-to- human transmission of avian flu," said Sen. Tom
Harkin (D-Iowa), the bill's main sponsor.
. But the disease has sickened 121
people and killed 62 in Southeast Asia since late 2003, according to an Oct. 24
update from the World Health Organization.
Sen. Ted Stevens (R-Alaska), who leads the Senate Appropriations Committee,
criticized the bill.